The dermis is more than skin.
It is a therapeutic interface.
Gylden leverages the unique biology of the dermis to enable rapid systemic drug delivery and precision immune activation.
Intradermal delivery improves both therapeutic exposure and immune activation —
The foundation for both Gylden platforms.
